To study different doses of magnesium sulphate with bupivacaine under spinal anesthesia in surgeries below umbilicus
Phase 2
Completed
- Registration Number
- CTRI/2015/07/005963
- Lead Sponsor
- DR RPGMC Kangra at Tanda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
ASA class 1&2
BMI 18.5-39.9
UNDERGOING INFRAUMBILICAL SURGERIES
Exclusion Criteria
Patients refusal for spinal anesthesia
Uncontrolled hypertension
Patients noted to have dysrhythmias on ECG
Allergic to study drugs
Absolute contraindication for spinal anesthesia
BMI >40
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a.To study the onset and duration of sensory and motor block. <br/ ><br> <br/ ><br>b.To study the duration of postoperative analgesia and post operative analgesic requirementsTimepoint: a. assesment done every 1 min upto 10 min, then every 5 min upto 30 min,every 10 min upto 60 min,15 min upto 120 min, then 30 min until end of surgery. <br/ ><br>b.postoperatively follow up done every hour upto first 6 hrs,then 2 hrly upto 12 hrs,then 3hrly upto 24 hrs.
- Secondary Outcome Measures
Name Time Method Hemodynamaic stability (Blood presssure,Heart rate,Respiratory rate,Oxygen saturation)throughout the surgery.Timepoint: Assesment done every 1 min upto first 10 min, then every 5 min upto 30 min,every 10 min upto 60 min,15 min upto 120 min, then 30 min until end of surgery.